RedHill Biopharma (RDHL) Non Operating Income (2012 - 2023)
RedHill Biopharma (RDHL) posted quarterly Non Operating Income of -$63.9 million for Q4 2022, down 116.18% year-over-year from $394.7 million in Q4 2021, and down 323.37% quarter-over-quarter from $28.6 million in Q3 2022.
RedHill Biopharma (RDHL) Non Operating Income (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported Non Operating Income for 11 consecutive years, with -$63.9 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Non Operating Income fell 116.18% year-over-year to -$63.9 million; the TTM figure through Dec 2022 stood at -$28.8 million (down 73.55% YoY), while the FY2025 annual figure was -$138000.0, down 102.02% from the prior year.
- Non Operating Income declined to -$63.9 million in Q4 2022 per RDHL's latest filing, from $28.6 million in the prior quarter.
- Across five years, Non Operating Income topped out at $28.6 million in Q3 2022 and bottomed at -$63.9 million in Q4 2022.
- Historically, Non Operating Income has averaged -$1.7 million across 5 years, with a median of $1.1 million in 2018.
- Annual changes were most pronounced in 2020 — Non Operating Income soared 46522.22% — and 2021, when it sank 739.07%.
- RedHill Biopharma's Non Operating Income stood at -$2.4 million in 2018, then jumped by 96.91% to -$73000.0 in 2019, then soared by 6432.88% to $4.6 million in 2020, then tumbled by 739.07% to -$29.5 million in 2021, then tumbled by 116.18% to -$63.9 million in 2022.
- Business Quant data shows RDHL's Non Operating Income at -$63.9 million in Q4 2022, $28.6 million in Q3 2022, and $2.6 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 47.49 Mn |
| Mar 31, 2023 | -21.16 Mn |
| Dec 31, 2022 | -63.87 Mn |
| Sep 30, 2022 | 28.59 Mn |
| Jun 30, 2022 | 2.55 Mn |
| Mar 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | -29.54 Mn |
| Sep 30, 2021 | 3.99 Mn |
| Jun 30, 2021 | 4.24 Mn |
| Mar 31, 2021 | 4.71 Mn |
| Dec 31, 2020 | 4.62 Mn |
| Sep 30, 2020 | 4.18 Mn |
| Jun 30, 2020 | 3.55 Mn |
| Mar 31, 2020 | 141,000.00 |
| Dec 31, 2019 | -73,000.00 |
| Sep 30, 2019 | -9,000.00 |
| Jun 30, 2019 | -1.47 Mn |
| Mar 31, 2019 | 657,000.00 |
| Dec 31, 2018 | -2.36 Mn |
| Sep 30, 2018 | 347,000.00 |